Akeso, Inc. (HKG:9926)
Hong Kong
· Delayed Price · Currency is HKD 80.90
+1.40 (1.76%)
May 13, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 72.61 billion as of May 13, 2025. Its market cap has increased by 78.43% in one year.
Market Cap
72.61B
Enterprise Value
68.93B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
80.90
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 72.61B, an increase of 291.57%. That is a compound annual growth rate of 31.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 72.61B | 33.28% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 194.78B |
| Hansoh Pharmaceutical Group Company | 140.92B |
| JD Health International | 117.99B |
| WuXi Biologics | 93.82B |
| Innovent Biologics | 86.36B |
| Alibaba Health Information Technology | 80.09B |
| Sichuan Kelun-Biotech Biopharmaceutical | 71.46B |
| Sino Biopharmaceutical | 69.96B |